ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis
More about Open Access at the CrickAuthors list
Marc Hennequart Steven Pilley Christiaan F Labuschagne Jack Coomes Loic Mervant Paul Driscoll Nathalie Legrave Younghwan Lee Peter Kreuzaler Benedict Macintyre Yulia Panina Julianna Blagih David Stevenson Douglas Strathdee Deborah Schneider-Luftman Eva Gronroos Eric Cheung Mariia Yuneva Charles Swanton Karen VousdenAbstract
Mitochondrial 10-formyltetrahydrofolate (10-formyl-THF) is utilized by three mitochondrial enzymes to produce formate for nucleotide synthesis, NADPH for antioxidant defense, and formyl-methionine (fMet) to initiate mitochondrial mRNA translation. One of these enzymes-aldehyde dehydrogenase 1 family member 2 (ALDH1L2)-produces NADPH by catabolizing 10-formyl-THF into CO2 and THF. Using breast cancer cell lines, we show that reduction of ALDH1L2 expression increases ROS levels and the production of both formate and fMet. Both depletion of ALDH1L2 and direct exposure to formate result in enhanced cancer cell migration that is dependent on the expression of the formyl-peptide receptor (FPR). In various tumor models, increased ALDH1L2 expression lowers formate and fMet accumulation and limits metastatic capacity, while human breast cancer samples show a consistent reduction of ALDH1L2 expression in metastases. Together, our data suggest that loss of ALDH1L2 can support metastatic progression by promoting formate and fMet production, resulting in enhanced FPR-dependent signaling.
Journal details
Journal Cell Reports
Volume 42
Issue number 6
Pages 112562
Available online
Publication date
Full text links
Publisher website (DOI) 10.1016/j.celrep.2023.112562
Europe PubMed Central 37245210
Pubmed 37245210
Keywords
Related topics
Type of publication